Expert bioDoctor Bruno Paiva is a research fellow of the departments of Haematology and Immunology at the Clinica Universidad de Navarra (CUN) and Centro de Investigaciones Medicas Aplicadas (CIMA), Pamplona, Spain. Dr Paiva is also the director of the Flow Cytometry Core and scientific coordinator of CIMA LAB Diagnostics, the laboratory diagnostic core of the University of Navarra. He graduated in pharmaceutical sciences at the University of Coimbra, Portugal, in 2007. He then spent a training period with Professor Alberto Orfao focusing on immunophenotypic in acute myeloid leukaemia.
Afterwards, he joined the immunopathology laboratory in the Haematology Department at the University Hospital of Salamanca, and started a PhD program under the supervision of Professor Jesús F. San Miguel. He received his PhD in 2011 from the Medical School of the University of Salamanca, where he studied the clinical value of multiparameter flow cytometry immunophenotyping of plasma cells in multiple myeloma patients.
Dr Paiva’s main area of work is on multiparameter flow cytometry evaluation of haematological malignancies. His main research interests focus on improving the differential diagnosis, risk stratification, and monitoring of patients with haematological malignancies, particularly monoclonal gammopathies such as MGUS (Monoclonal Gammopathy of Undetermined Significance), smouldering and symptomatic multiple myeloma, Waldenström’s macroglobulinaemia, amyloidosis but also acute leukaemia’s and lymphoproliferative disorders.
During the 2015 International Myeloma Workshop (IMW) he received the prestigious Bart Barlogie Young Investigator Award, which honours investigators under 40-year-old who have made major scientific contributions in terms of publications, funding received and prior awards or recognition. Dr Paiva is an author or co-author of several publications in peer reviewed journals.